Kumar Srinivasan
Direttore/Membro del Consiglio presso TRANSCENTA HOLDING LIMITED
Patrimonio netto: 6 943 $ in data 30/04/2024
Provenienza dei contatti di primo grado di Kumar Srinivasan
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 19 | |
Wugen, Inc.
 Wugen, Inc. Packaged SoftwareTechnology Services Wugen, Inc. develops CAR-T therapy platform for cancer therapies. The company was founded by Matthew Cooper and John F. DiPersio and is headquartered in St. Louis, MO.
12
| Holding Company | Packaged Software | 12 |
Pulmotect, Inc.
 Pulmotect, Inc. BiotechnologyHealth Technology Pulmotect, Inc. develops clinical stage, novel, pathogen-agnostic, inhaled compound for the prevention and early treatment of acute, severe viral and bacterial respiratory infections. It provides safe, broad-spectrum, fast-acting protection against bacterial pneumonia (including MRSA), influenza, fungal pneumonia, and Class A bioterror agents (including anthrax, tularemia, and plague). The company was founded by Brenton Scott and Magnus Hook in 2007 and is headquartered in Houston, TX.
8
| Holding Company | Biotechnology | 8 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Kumar Srinivasan tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Director/Board Member | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Fannin Partners LLC
 Fannin Partners LLC Investment ManagersFinance Fannin Partners LLC (Fannin Partners) is a venture capital firm founded in 2005 by Leo E. Linbeck III. The firm is headquartered in Houston, Texas. | Investment Managers | Private Equity Investor Founder | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Abingworth LLP
 Abingworth LLP Investment ManagersFinance Abingworth LLP (Abingworth) is a venture capital firm founded in the year 1973 Peter Dickson and Anthony Montagu. The firm headquartered in London and additional offices in San Francisco and Boston. Abingworth LLP became part of The Carlyle Group Inc. (NASDAQ: CG) on 3rd August 2022. | Investment Managers | Chief Investment Officer Private Equity Investor | |
| University of Oxford | College/University | Corporate Officer/Principal Doctorate Degree | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Doctorate Degree Graduate Degree | |
MVM Partners LLP
 MVM Partners LLP Investment ManagersFinance MVM Partners LLP (MVM Partners) is a venture capital firm founded in 1997. The firm is headquartered in London, the United Kingdom. | Investment Managers | Private Equity Investor Private Equity Investor | |
| University of Cambridge | College/University | Doctorate Degree Undergraduate Degree | |
| Massachusetts Institute of Technology | College/University | Masters Business Admin Undergraduate Degree | |
| The University of Chicago | College/University | Masters Business Admin Doctorate Degree | |
| The Johns Hopkins University | College/University | Graduate Degree Doctorate Degree | |
| AMBRX INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| University College London | College/University | Undergraduate Degree Doctorate Degree | |
| The Rockefeller University | College/University | Doctorate Degree | |
| Ghent University | College/University | Doctorate Degree | |
| Fudan University | College/University | Undergraduate Degree General Counsel Undergraduate Degree | |
Reliance Life Sciences Pvt Ltd.
 Reliance Life Sciences Pvt Ltd. Miscellaneous Commercial ServicesCommercial Services Reliance Life Sciences Pvt Ltd. provides biotechnology clinical research services. Its services include pre clinical services, phase-I, biometrics, cardiac safety studies, medical writing, and pharmacovigilance. The company was founded by Dhirubhai H. Ambani in 2001 and is headquartered in Mumbai, India. | Miscellaneous Commercial Services | President | |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal | |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
BioHouston, Inc.
 BioHouston, Inc. Miscellaneous Commercial ServicesCommercial Services BioHouston, Inc. engages in life science and biotechnology commercialization. The firm's mission is to create an environment that will stimulate technology transfer and research commercialization, thereby generating economic wealth for the Houston region and making it a global competitor in life science commercialization. The company is headquartered in Houston, TX. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
The Indus Entrepreneurs
 The Indus Entrepreneurs Miscellaneous Commercial ServicesCommercial Services The Indus Entrepreneurs is a non-profit organization. It provides mentoring, networking, education and funding to entrepreneurs. The company was founded in 1992 and is headquartered in Santa Clara, CA. | Miscellaneous Commercial Services | Director/Board Member | |
European Society for Medical Oncology
 European Society for Medical Oncology Medical/Nursing ServicesHealth Services The European Society for Medical Oncology (ESMO) is a leading medical oncology society that provides a professional network for its members and works with national societies across Europe. The non-profit company is based in Lugano, Switzerland. ESMO's position on a wide range of legislative and non-legislative policy files on both EU and levels is available to learn about. Raffaella Casolino is the third ESMO young medical oncologist serving as a cancer expert on the WHO Cancer Control team. ESMO's Young Oncologists Corner is dedicated to providing educational and networking opportunities for medical oncologists under 40. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal | |
LAV Management Co., Ltd.
 LAV Management Co., Ltd. Investment ManagersFinance LAV Management Co., Ltd. (LAV) is a venture capital subsidiary of Eli Lilly & Co. founded in 2008. The firm is headquartered in Shanghai, China with branches located in Central, Hong Kong and California, United States. | Investment Managers | Corporate Officer/Principal | |
Aquinas Cos. LLC
 Aquinas Cos. LLC Engineering & ConstructionIndustrial Services Aquinas Cos. LLC provides construction services. It provides project planning, project management and construction management services to clients developing real estate assets that serve corporate, hospitality, retail, healthcare, education and cultural markets. The company was founded in 1938 and is headquartered in Houston, TX. | Engineering & Construction | Chief Executive Officer | |
| USC Marshall School of Business | College/University | Masters Business Admin Masters Business Admin | |
| Peking Union Medical College | College/University | Undergraduate Degree Doctorate Degree | |
| The BayHelix Group | Corporate Officer/Principal | ||
Exicure Operating Co.
 Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| MIT Sloan School of Management | College/University | Director/Board Member | |
Ansun Biopharma, Inc.
 Ansun Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ansun Biopharma, Inc. manufactures pharmaceutical products. Its products include Fludase, a drug candidate for the prophylaxis and treatment of respiratory infections caused by various types of influenza virus, including the types of virus that may cause a potential influenza pandemic, as well as various types of parainfluenza virus. The company was founded by Nancy Chang on August 9, 2012 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | President | |
Veritas Genetics, Inc.
 Veritas Genetics, Inc. Miscellaneous Commercial ServicesCommercial Services Veritas Genetics, Inc. provides breast and ovarian cancer genetic testing services. It operates business through Veritas whole genome sequencing and targeted genetic testing products. The company was founded by Mirza Cifric, Preston Estep III, Joseph Thakuria, Jonathan Zhao and George MacDonald Church in 2014 and is headquartered in Danvers, MA. | Miscellaneous Commercial Services | Founder | |
Just - Evotec Biologics, Inc.
 Just - Evotec Biologics, Inc. Specialty StoresRetail Trade Just Biotherapeutics, Inc. operates as biotechnology firm. Its products include biosimilars and novel and repositioned biologics. The firm also offers molecular design, process and product platform and manufacturing and plant design services. The company was founded by James N. Thomas, Victor P. Fung, Dean K. Pettit, and Yining Zhao in 2014 and is headquartered in Seattle, WA. | Specialty Stores | Founder | |
Suzhou Chuangsheng Pharmaceutical Group Co., Ltd.
 Suzhou Chuangsheng Pharmaceutical Group Co., Ltd. BiotechnologyHealth Technology MabSpace Biosciences (Suzhou) Co., Ltd. engages in the development of therapeutic antibodies for cancer and fibrotic diseases. Its products include humanized programmed death-ligand 1, humanized vascular endothelial growth factor receptors 2, humanized OX40, and humanized colony stimulating factor 1 receptor antibodies. It also offers programmed death-ligand 1 antibodies for Immunohistochemistry detection and soluble programmed death ligand 1 measurement. The company was founded by Xue Ming Qian on October 18, 2012 and is headquartered in Suzhou, China. | Biotechnology | Chief Executive Officer | |
Glycomine, Inc.
 Glycomine, Inc. BiotechnologyHealth Technology Glycomine, Inc. engages in the development of therapeutics for diseases which have no treatment options. Its therapeutic approach is to combine replacement therapies such as substrates, enzymes, or proteins with intracellular delivery vehicles consisting of bio-nanomaterials or ligands that target the molecules to the cell interior of clinically relevant organs. It focuses on research of mannose-1-phosphate and Ngly1 enzyme replacement therapy, and observational study of GLY-000. The company was founded in 2014 by Agnes Rafalko and is headquartered in San Carlos, CA. | Biotechnology | Director/Board Member | |
| EXICURE, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Beijing Shenogen Pharma Group Ltd.
 Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| Columbia University Vagelos College of Physicians & Surgeons | College/University | Graduate Degree | |
Allterum Therapeutics, Inc.
 Allterum Therapeutics, Inc. BiotechnologyHealth Technology Allterum Therapeutics, Inc. is a bio-pharmaceutical company. It develops 4A10, a monoclonal antibody therapy for pediatric acute lymphoblastic leukemia. The company was founded in 2018 and is headquartered in Houston, TX. | Biotechnology | Chief Executive Officer | |
Anjarium Biosciences AG
 Anjarium Biosciences AG BiotechnologyHealth Technology Anjarium Biosciences AG is a Swiss company that focuses on creating a new class of non-viral gene therapies to tackle genetic diseases throughout a patient's lifetime. The company is based in Schlieren, Switzerland. The company's versatile platform leverages breakthrough science and expertise at the interface of genetic medicine, synthetic biology, and nanoparticle engineering to generate a pipeline of advanced gene therapies with unique competitive advantages over current viral-vector based gene therapies. Anjarium's investors include leading international and strategic investors such as Abingworth, Gimv, Omega Funds, Pfizer Ventures, and Surveyor Capital. The company was founded by Joël de Beer, and Stephen Yoo has been the CEO of the company since 2022. | Biotechnology | Director/Board Member | |
| HJB (Hangzhou) Co. Ltd. | Director/Board Member | ||
| Intuition Biosciences, Inc. | Founder | ||
| Every Texan | Director/Board Member | ||
BiOneCure Therapeutics, Inc.
 BiOneCure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology BiOneCure Therapeutics, Inc. is a clinical stage biopharmaceutical company based in Germantown, MD. The private company is dedicated to developing innovative antibody-based medicines for the treatment of cancer and enhancing cancer patients' lives. The company has developed proprietary payload platforms that enable a tailor-made approach for ADC drug development. The company is led by industry veterans from Pfizer, AstraZeneca, Amgen, and other similar companies with successful drug discovery and development experience in the ADC field. The company's mission is to provide first-in-class and antibody-based medicines to cancer patients with unmet medical needs. The company was founded in 2017 by Haifeng Bao and Yi Ning Zhao, and Haifeng Bao has been the CEO since incorporation. | Pharmaceuticals: Major | Founder | |
| Hangzhou Veritas Genetics, Inc. | Chief Executive Officer | ||
Launch Therapeutics, Inc.
 Launch Therapeutics, Inc. Financial ConglomeratesFinance Launch Therapeutics, Inc. provides investment and therapies development services. The CEO of the American company is Anshul Thakral. | Financial Conglomerates | Director/Board Member | |
| Shanghai Medical College of Fudan University | College/University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 33 |
| Cina | 9 |
| Regno Unito | 6 |
| Svizzera | 3 |
| Belgio | 2 |
Settori
| Health Technology | 15 |
| Consumer Services | 15 |
| Finance | 7 |
| Commercial Services | 7 |
| Health Services | 3 |
Posizioni
| Director/Board Member | 118 |
| Corporate Officer/Principal | 79 |
| Independent Dir/Board Member | 28 |
| Undergraduate Degree | 26 |
| Chief Tech/Sci/R&D Officer | 23 |
Contatti più connessi
| Insiders | |
|---|---|
| Peter Kiener | 25 |
| John McKearn | 25 |
| Bosun Hau | 23 |
| Mark Alles | 20 |
| Bali Muralidhar | 20 |
| Yi Ning Zhao | 16 |
| Bruce Given | 16 |
| Kwan Wai Leung | 15 |
| Atul Varadhachary | 15 |
| Xue Ming Qian | 13 |
| Colin Broom | 12 |
| Jun Bao | 12 |
| Natalie Mount | 10 |
| Mark Benedyk | 9 |
| Jim Gamett | 9 |
- Borsa valori
- Insiders
- Kumar Srinivasan
- Connessioni Società
